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The human transcriptome is so large, diverse, and
dynamic that, even after a decade of investigation
by RNA sequencing (RNA-seq), we have yet to
resolve its true dimensions. RNA-seq suffers from
an expression-dependent bias that impedes charac-
terization of low-abundance transcripts. We per-
formed targeted single-molecule and short-read
RNA-seq to survey the transcriptional landscape of
a single human chromosome (Hsa21) at unprece-
dented resolution. Our analysis reaches the lower
limits of the transcriptome, identifying a fundamental
distinction between protein-coding and noncoding
gene content: almost every noncoding exon un-
dergoes alternative splicing, producing a seemingly
limitless variety of isoforms. Analysis of syntenic re-
gions of the mouse genome shows that few noncod-
ing exons are shared between human andmouse, yet
human splicing profiles are recapitulated on Hsa21 in
mouse cells, indicative of regulation by a deeply
conserved splicing code. We propose that noncod-
ing exons are functionally modular, with alternative
splicing generating an enormous repertoire of poten-
tial regulatory RNAs and a rich transcriptional reser-
voir for gene evolution.
INTRODUCTION
The genome is transcribed into a diverse range of protein-coding
and noncoding RNAs collectively termed the transcriptome. The
human transcriptome is so large and complex that, even after a
decade of investigation by RNA sequencing (RNA-seq), we are
yet to achieve a complete census of gene expression. Moreover,Cell Systems 6, 245–255, Februarour view of a gene as a discrete entity, and of a single protein-
coding gene as the functional unit of inheritance, has been
undermined by the recognition of pervasive transcription across
the genome and interleaved alternative isoforms at individual loci
(Carninci et al., 2005; Clark et al., 2011; Djebali et al., 2012; Kap-
ranov et al., 2005; Mercer et al., 2011; Sharon et al., 2013; Tilgner
et al., 2015).
RNA-seq has revealed an abundance of small and large non-
protein-coding RNAs that are antisense, intronic, or intergenic to
protein-coding genes (Derrien et al., 2012; Hon et al., 2017; Iyer
et al., 2015; You et al., 2017). Similarly, many protein-coding
genes express alternative isoforms that lack extended open
reading frames (ORFs; Gonza`lez-Porta et al., 2013). These find-
ings have fueled one of the major debates of modern genetics:
the functional relevance of noncoding RNA expression.
The initial sequencing of the human genome provided a cata-
log of around 20,000 protein-coding genes (Lander et al., 2001).
However, at least as many long noncoding RNAs (lncRNAs) have
since been identified, and new studies routinely discover novel
genes and isoforms (Hon et al., 2017; Iyer et al., 2015; Sharon
et al., 2013; Tilgner et al., 2015; You et al., 2017). This failure to
achieve a comprehensive annotation of the transcriptome is
partly due to the expression-dependent bias of RNA-seq, which
limits the capacity of this technique to resolve low-abundance
transcripts (Hardwick et al., 2016). This has impeded the discov-
ery and characterization of lncRNAs, which are typically weakly
expressed (Cabili et al., 2011; Derrien et al., 2012). As a result,
our understanding of lncRNA biology has been largely informed
by studying only those examples with sufficient expression for
analysis by RNA-seq.
Another limitation of traditional RNA-seq is the reliance on
computational assembly of full-length isoforms from short
(100–150 bp) sequencing reads. This is a difficult task,
particularly when alternative splicing generates multiple partially
redundant isoforms at an individual locus (Conesa et al., 2016).
With the emergence of technologies for long-read sequencing
it is now possible to read full-length isoforms as singley 28, 2018 Crown Copyright ª 2017 Published by Elsevier Inc. 245
molecules, negating the challenges posed by transcript assem-
bly. Leading studies have highlighted the utility of single-mole-
cule techniques for resolving complex and precisely organized
alternative splicing events (Sharon et al., 2013; Tilgner et al.,
2015). However, depth remains a constraint, with rare transcripts
often falling below the limits of sampling.
Here, we have attempted to reach the lower limits of the tran-
scriptome by surveying gene expression from a single human
chromosome at unprecedented resolution. Chromosome 21
(Hsa21) is the smallest human chromosome (48 Mb), is typical
of the human genome in many features (e.g., gene content and
repeat density; Figure S1), and has accordingly been used as a
model system in transcriptomics (Cawley et al., 2004; Kampa
et al., 2004). With trisomy of Hsa21 being the most common
chromosomal aneuploidy in live-born children and the most
frequent genetic cause of mental retardation, the gene content
of this chromosome is also the subject of medical interest (Dier-
ssen, 2012; Letourneau et al., 2014).
To resolve the complete expression profile of Hsa21 while
excluding the remainder of the genome, we used targeted
RNA-seq (CaptureSeq; Mercer et al., 2014). Complementary
oligonucleotide probes were tiled across the chromosome to
capture expressed transcripts that were then sequenced deeply
on single-molecule and short-read platforms. This approach re-
duces the influence of the expression-dependent bias inherent
to RNA-seq, allowing gene populations encoded within this
cross-section of the genome to be observed at high resolution.
This reveals a fundamental distinction in the architecture of
protein-coding and noncoding RNA.
RESULTS
Targeted RNA-Seq Analysis of Human Chromosome 21
Two limitations of traditional RNA-seq have ensured that,
despite considerable attention, the true dimensions of the
human transcriptome remain unresolved. First, because
sequencing reads are competitively sampled from a single
pool in which transcripts of varied abundance are proportionally
represented, weakly expressed transcripts commonly evade
detection (Clark et al., 2011; Hardwick et al., 2016). Second,
the accurate assembly of full-length isoforms from short
sequencing reads is challenging, particularly whenmultiple alter-
native isoforms are transcribed from a single locus (Conesa
et al., 2016; Tilgner et al., 2015).
To address these challenges, we performed single-molecule
(PacBio RSII) and short-read (Illumina HiSeq) RNA CaptureSeq,
targeting the complete expression profile of Hsa21. We gener-
ated biotin-labeled oligonucleotide probes tiling the entire
nonrepetitive Hsa21 sequence. These were used to capture
full-length cDNA molecules, thereby restricting sequencing to
transcripts expressed on Hsa21 (STAR Methods).
To establish our approach, we first performed short-read
sequencing on Hsa21-enriched cDNA libraries from the human
K562 cell type and compared these with K562 samples analyzed
in parallel by conventional RNA-seq (STAR Methods). Whereas
just 1.3% of reads from RNA-seq libraries were uniquely aligned
to Hsa21, this figure rose to 71.8% after capture, equating to a
54-fold coverage enrichment (Table S1). Analysis of ERCC
(External RNA Controls Consortium) spike-in controls confirmed246 Cell Systems 6, 245–255, February 28, 2018that RNA CaptureSeq accurately measured transcript abun-
dances within the physiological range of gene expression (Fig-
ures S2A and S2B), as previously demonstrated (Clark et al.,
2015; Mercer et al., 2014). The legitimacy of novel splice junc-
tions identified by CaptureSeq was also verified by RT-PCR
and Sanger sequencing (16 of 20 randomly selected examples;
Figure S2C and Table S2).
Next, we analyzed Hsa21-enriched cDNA from human testis
by deep single-molecule sequencing (STAR Methods). Testis
exhibits a distinctly promiscuous transcriptional profile (Soumil-
lon et al., 2013), marking this as an ideal tissue within which to
conduct a broad survey of gene content encoded on Hsa21.
We obtained 387,029 full-length nonchimeric reads aligning to
Hsa21, representing 910 Mb of usable transcript sequence
concentrated in 1.5% of the genome. After filtering, we
retrieved 101,478 full-length multi-exonic transcript reads on
Hsa21 (Table S3; Figures S3A and S3B).
To reinforce single-molecule isoforms and, more importantly,
enable quantitative analyses of expression and splicing, we
also performed very deep short-read sequencing on Hsa21-en-
riched cDNA from testis, brain, and kidney (STAR Methods). An
average 65-fold coverage enrichment, relative to conventional
RNA-seq, was achieved, and at least 100 million reads uniquely
aligning to Hsa21 were obtained for each tissue (Table S4).
Strong correspondence between spliced short-read alignments
and single-molecule transcripts in our Hsa21 transcriptome
profile was observed, with 84.7% of alignment junctions being
concordant with introns in single-molecule transcripts (Figures
S3C and S3D). Because long PacBio reads provide reliable
transcript scaffolds, while read counts for short Illumina reads
accurately estimate the abundance of known isoforms, our
combined CaptureSeq approach permits robust quantitative
transcriptome analyses that do not rely on de novo transcript
assembly.
Transcriptional Landscape of Human Chromosome 21
Hsa21 has frequently been used as a cross-sectional model for
genomics because it is small (48 Mb; 1.5% of the genome)
and typical in terms of gene content, repeat density, and other
features (Figure S1; Cawley et al., 2004; Kampa et al., 2004).
Our targeted analysis showed that essentially all (nonrepeti-
tive) regions of Hsa21 encode spliced gene loci, greatly reducing
intergenic regions (Figure 1A). This is best illustrated in two
‘‘gene deserts’’ that flank the NCAM2 gene (extending 2.6 Mb
upstream and 4.0 Mb downstream), which were largely devoid
of transcript annotations. We discovered that these regions
harbored numerous large, multi-exonic, and richly alternatively
spliced lncRNAs (Figure 1B).
At protein-coding loci on Hsa21 we identified 7,310 unique
multi-exonic isoforms, of which 77% were novel, with respect
to current annotations (a combined transcriptome catalog of
Gencode v19, MiTranscriptome v2, and FANTOM5; Figure 1C;
Tables S5 and S6). Novel isoforms encoded up to 2,365 possible
ORFs that were not currently annotated, encompassing 291
novel coding exons and 845 novel ORF introns (Figure 1C; for
examples see Figure S4). Although these are predicted ORFs
only, and the precise number retrieved is influenced by the
choice of cutoff parameters (STAR Methods), this represents a
considerable increase on existing annotations.
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Figure 1. Transcriptional Landscape of Human Chromosome 21
(A) Transcriptional activity recorded across the major arm of human chromosome 21 (Hsa21) by short-read and single-molecule RNA CaptureSeq. Normalized
coverage (log scale) from short-read alignments is shown for brain (blue), kidney (purple), and testis (red), with coverage from traditional RNA-seq (in K562 cells;
navy) shown for comparison. The coverage tracks shown below are all unique internal exons (black) from transcripts resolved by single-molecule sequencing.
Unique internal exons from the Gencode (v19) reference catalog are shown for comparison.
(legend continued on next page)
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While this suggests that the protein-coding content of Hsa21
may be underestimated, most novel isoforms to protein-coding
genes were noncoding isoform variants or possessed novel
UTRs. Alternative splicing of UTRs (both 50 and 30) was common
and often highly complex (for examples see Figure S5). Single-
molecule sequencing was particularly useful for resolving UTR
variants, since it does not suffer from sequencing ‘‘edge effects’’
that affect short-read transcript assembly (Martin and Wang,
2011). In total, protein-coding loci on Hsa21 encoded 3,931
unique internal exons (34% novel) and 6,365 unique canonical
introns (43% novel; Figure 1C; Tables S5 and S6).
At noncoding loci, we identified 1,589 isoforms across Hsa21,
encompassing 1,663 unique internal exons (45% novel) and
3,210 unique canonical introns (55% novel; Figure 1C; Tables
S5 and S6). Examples of rich isoform diversity at lncRNA loci
were routinely resolved with targeted single-molecule
sequencing (Figures 1B and S6). Inmany instances, multiple par-
tial lncRNA annotations were incorporated into single unified loci
(Figures S6A–S6C), and the splicing of lncRNAswith neighboring
protein-coding genes to form extensively spliced UTRs was also
frequently observed (Figure S6D).
By extrapolating our Hsa21 annotations across the broader
human genome, we can estimate the existence of 383,000
unique isoforms to protein-coding genes that encompass
147,000 possible ORFs. We predict noncoding gene loci to ex-
press 98,000 multi-exonic isoforms (2.1-fold increase by com-
parison with Gencode v26), incorporating 88,000 internal exons
(1.2-fold) and 168,000 introns (1.7-fold). While we have profiled
only three tissues, ensuring that these are lower-bound esti-
mates, it is clear that a large amount of transcriptional diversity
remains unexplored.
Universal Alternative Splicing of Noncoding Exons
To determine whether RNA CaptureSeq provided a complete
profile of transcription on Hsa21, or whether further isoforms
remain to be discovered, we generated discovery-saturation
curves by incremental subsampling of short-read alignments
(STAR Methods). The detection of protein-coding exons and
introns approached saturation at a fraction of library depth, indi-
cating that these were near comprehensively sampled (Fig-
ure 2A; note that terminal exons were not considered in this
analysis). While the detection of noncoding exons also ap-
proached saturation, the discovery of noncoding introns (and
consequently additional noncoding isoforms) continued pro-
gressively toward maximum sequencing depth (Figure 2A).
This indicates that although the majority of exons were discov-
ered, noncoding isoforms were not exhaustively resolved, even
with the enhanced sensitivity afforded by RNA CaptureSeq.
Because each unique intron represents a different splicing
event, this result suggests that alternative splicing generates a(B) Inset from (A): detail of intergenic regions flanking the protein-coding gene NC
noncoding RNAs (lncRNAs) were detected. Red and blue insets show single-mo
molecule RNA CaptureSeq data extend the gene model for the previously annota
opposite direction. Both exhibit extensive alternative splicing, in contrast to NCA
(C) The number of unique internal exons, unique canonical introns, and nonredu
protein-coding genes (upper) and noncoding loci (lower) are shown separately an
UTR variants (green) are distinguished from predicted ORFs (blue).
(D) The proportion of captured bases on Hsa21 that are exonic, intronic, or silen
248 Cell Systems 6, 245–255, February 28, 2018seemingly limitless diversity of noncoding isoform variants. To
confirm this, we assessed the alternative splicing of internal
exons according to percent splice inclusion (PSI) scores (STAR
Methods). Unlike protein-coding exons (median PSI = 90.5%),
almost all noncoding exons were alternatively spliced (median
PSI = 55.5%; Figures 2B and S7). The relative abundances of
coding and noncoding introns, compared with exons, further
supports this finding; we found that the relative difference be-
tween coding and noncoding introns (49.8-fold) is larger than
for exons (19.2-fold; Figure 2C), reflecting the greater isoform di-
versity generated by enriched alternative splicing of noncoding
RNAs. We use the phrase universal alternative splicing to
mean that nearly every noncoding exon is subject to alternative
splicing.
The distinction between coding and noncoding splicing is
illustrated by comparison of the protein-coding gene SAMSN1
with its antisense lncRNA (SAMSN1-AS1) and a nearby inter-
genic lncRNA (AJ006998.2). While the majority of single-mole-
cule SAMSN1 transcripts correspond to one of just two
mRNA isoforms for this gene, almost all SAMSN1-AS1 and
AJ006998.2 transcript molecules represent unique isoforms
(Figure 2D). Universal alternative splicing was not limited to
lncRNA exons but was similarly observed for untranslated exons
at protein-coding loci (located in 50 or 30 UTRs, or specific to non-
coding isoforms; Figures S8 and S9). For example, the 50 UTR of
the protein-coding gene CHODL exhibited extensive alternative
splicing (Figure S10). Splice acceptor sites at lncRNA and UTR
exons harbored canonical splicing elements that were indistin-
guishable from those foundat protein-coding exons (FigureS8B),
confirming that noncoding exons are demarcated by bona fide
rather than cryptic splice sites.
Our analysis reveals a fundamental distinction between the or-
ganization of protein-coding and noncoding gene content. While
the diversity of protein-coding isoforms is limited by the require-
ment to maintain an ORF, no such constraint is imposed on non-
coding RNA, allowing the spliceosome to explore the full range of
noncoding exon combinations to generate an effectively inex-
haustible noncoding isoform diversity. It is worth noting here
that this phenomenon is not limited to obscure noncoding
RNAs encoded on Hsa21: using publicly available data (Cabili
et al., 2011; Clark et al., 2015; Iyer et al., 2015) we examined
four well-known functional lncRNAs—XIST, HOTAIR, GOMAFU,
andH19—and revealed rich isoform diversity and near-universal
alternative splicing at each locus (Figure S11).
Comparison of Transcriptional Landscapes in Human
and Mouse
To establish whether the novel genes and isoforms unearthed on
Hsa21 were conserved between human and mouse, and to
determine whether noncoding exons are similarly enriched forAM2 (2.6 Mb upstream and 4.0 Mb downstream), in which multiple novel long
lecule reads supporting NCAM2 (blue) and two nearby lncRNAs (red). Single-
ted lncRNA AP000946.2 and resolve a novel lncRNA that is transcribed in the
M2, where the majority of reads represents redundant isoforms.
ndant isoforms resolved by single-molecule RNA CaptureSeq. Content from
d, for protein-coding genes, exons/introns belonging to noncoding isoforms or
t, according to Gencode (v19; left) and RNA CaptureSeq (right).
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D
Figure 2. Universal Alternative Splicing of Noncoding Exons
(A) Discovery-saturation curves show the rate of detection for unique protein-coding/noncoding introns and unique internal exons (from the single-molecule
Hsa21 transcriptome) relative to short-read sequencing depth. Depth fraction is relative to a combined pool of450 million short-read alignments to Hsa21 from
testis, brain, and kidney.
(B) Cumulative frequency distributions show percent splice inclusion (PSI) scores for protein-coding/noncoding internal exons in human and mouse tissues.
(C) Binned frequency distributions show abundances of protein-coding/noncoding internal exons and introns in human testis (mean ± SD, n = 3). Gray line shows
total exon/intron population. Median fold difference between coding/noncoding populations is shown below.
(D) Illustrative examples of isoforms resolved by single-molecule RNA CaptureSeq in human tissues. Annotated transcripts (Gencode v19) and mapped single-
molecule isoform reads are shown at two loci: (i) the protein-coding gene SAMSN1 and the noncoding antisense RNA SAMSN1-AS1; and (ii) the lncRNA
AJ006998.2. Internal exons are identified as protein-coding (blue) or noncoding (red), which includes untranslated exons at protein-coding loci. Terminal exons
(black) were excluded from analyses.alternative splicing, we performed short-read RNA CaptureSeq
across mouse genome regions syntenic to Hsa21 (located on
mouse chromosomes 10, 16, and 17; Mouse Genome
Sequencing Consortium et al., 2002). We obtained transcrip-
tional profiles of equivalent depth to human samples within
matched mouse tissues (Table S7), enabling comparison of the
two transcriptomes at high resolution (STAR Methods).
As for Hsa21, the syntenic regions of the mouse genome were
pervasively transcribed, largely eroding intergenic desert regions
(Figure 3A). Spliced transcripts encompassed 80.5% of targetedbases in mouse, compared with 88.4% on Hsa21 (compare Fig-
ures 1D and 3B). In mouse, 25.1% of targeted bases were re-
tained as mature exons, compared with 16.7% in human, with
the remaining fraction (55.4% versus 71.7%) removed as introns
(compare Figures 1D and 3B). The larger fraction of bases
represented in mature exons in mouse (1.5-fold) likely reflects
compaction of the mouse genome via accelerated genetic loss
(Mouse Genome Sequencing Consortium et al., 2002; Vierstra
et al., 2014; Yue et al., 2014) rather than higher gene content,
with the mouse transcriptome assembly being somewhatCell Systems 6, 245–255, February 28, 2018 249
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Figure 3. Transcriptional Landscape of Mouse Syntenic Regions and Noncoding Exon Evolution
(A) Transcriptional activity recorded across regions of the mouse genome (Mmu16, Mmu17, Mmu10) syntenic to human chromosome 21 (Hsa21) by short-read
RNA CaptureSeq. Normalized coverage (log scale) of short-read alignments is shown for testis (red), with traditional RNA-seq (in MEL cells; navy) shown for
comparison. Coverage tracks shown below are all unique internal exons (black) from transcripts in the Gencode (vM15) reference catalog and those assembled
from RNA CaptureSeq data (testis, brain, and kidney combined).
(B) Bar charts show the number of protein-coding/noncoding unique internal exons, unique canonical introns, and unique transcript isoforms in Gencode (vM15)
annotations (upper) or assembled fromRNACaptureSeq (lower; brain, kidney, and testis combined). Pie charts indicate the proportion of captured bases that are
exonic, intronic, or silent.
(C) Upper: the fraction of coding/noncoding splice-site dinucleotides (AG/GT/both) detected on Hsa21 that are conserved in other vertebrate genomes (arranged
by million years to common ancestor). Lower: pie charts indicate the proportion of Hsa21 exons with splice-site dinucleotides that are conserved in the mouse
genome (red/blue) and the proportion for which an equivalent splice site could also be detected in mouse RNA CaptureSeq libraries (black).
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smaller than human (77%, based on unique internal exon count;
Table S8).
Although almost all protein-coding genes on Hsa21 have
mouse orthologs, we observed a higher frequency of alternative
splicing among human genes than their mouse counterparts:
69% of human protein-coding exons were classified as alterna-
tive (PSI < 95%) compared with just 31% in mouse (Figure 2B).
As a result of this greater splicing diversity, human protein-cod-
ing genes had more internal exons (17%), introns (39%), and
isoforms (65%) than their corresponding mouse orthologs
(Table S8).
The DYRK1A gene, a leading candidate for autism and
trisomy-21 phenotypes (Becker et al., 2014), provides an illustra-
tive example of the increased splicing diversity distinguishing hu-
man genes from their mouse orthologs. While we found no novel
exons or isoforms to theDyrk1A gene in themouse, we identified
six novel internal exons in the human brain (in addition to all 13
currently annotated DYRK1A exons; Figures 4A and 4B). Exten-
sive alternative splicing generated at least 11 novel DYRK1A
isoforms, of which 10 comprise noncoding variants and one
encodes a novel ORF with an N-terminal modification to the
DYRK1A protein (Figures 4A and 4B; interestingly, an analogous
N-terminal modification regulates subcellular localization of the
DYRK4 paralog [Papadopoulos et al., 2011]).
The majority of novel exons discovered in the mouse syntenic
regions were noncoding (Figure 3B), and these were similarly
subject to near-universal alternative splicing (Figure 2B). This in-
dicates that the size and structure of the human andmouse tran-
scriptomes are largely comparable, with each harboring large
noncoding RNA populations that exhibit prolific alternative
splicing.
Despite this similarity, we found that individual lncRNAs
were largely divergent between the two lineages (STAR
Methods). Nineteen percent of lncRNA splice-acceptor and
16% of splice-donor dinucleotides (AG/GT) were conserved
between the human and mouse genomes. However, a corre-
sponding splice site was found in mouse for fewer than 2% of
human sites, implying that noncoding exon orthologs are rare
(Figure 3C). Although they were poorly conserved relative to their
protein-coding counterparts, noncoding exons exhibited internal
sequence constraint (base on Vertebrate PhlyoP scores) compa-
rable with annotated DNase hypersensitive or transcription fac-
tor binding sites, with flanking splice sites showing a further,
though relatively modest, conservation enrichment (Figures
S12A and S12B). These data indicate that, while similar in size
and structure, human and mouse noncoding RNA populations
are largely distinct, echoing the reported divergence of regula-
tory elements between mouse and human genomes (Vierstra
et al., 2014; Villar et al., 2015).
Human Chromosome 21 Expression and Splicing in
Mouse Cells
The Tc1mouse strain is a model for trisomy-21 that carries a sta-
ble copy of Hsa21 (Yu et al., 2010). The Tc1mouse has also been
used to compare the human and mouse transcriptomes,
enabling the regulatory contributions of human cis elements
and mouse trans-acting factors to be distinguished (Barbosa-
Morais et al., 2012; Wilson et al., 2008). To investigate the regu-
lation of transcriptome diversity, we performed short-read RNACaptureSeq, targeting both Hsa21 and its syntenic mouse
genome regions, in matched tissues of the Tc1 mouse (Table
S9 and STAR Methods).
Most notably, the splicing profiles of genes encoded on Hsa21
were recapitulated in the Tc1mouse as for human tissues, rather
their mouse orthologs, where these were divergent. The
DYRK1A gene again provides an illustrative example, with
human-specific splice-site selection and quantitative exon us-
age faithfully recapitulated on Hsa21 in Tc1 samples (Figures
4A–4D). Globally, 87% of human-specific splice sites distin-
guishing human and mouse orthologs were also detected on
Hsa21 in the Tc1 mouse (compared with 82% for shared splice
sites; Figure S13A). Similarly, the alternative splicing frequency
of human exons remained 2.1-fold higher than for mouse ortho-
logs, and 88% of sites classified as alternative in human were
also classified as alternative in Tc1 (compared with 39% in
mouse; Figures S13B and S13C). When correlated according
to the PSI profiles across all orthologous splice sites, we found
that human, mouse, and Tc1 samples clustered according to
chromosomal, rather than organismal, origin (Figure S14C).
Together these data confirm the central importance of local cis
sequence elements in defining exon boundaries and alternative
exon inclusion.
The structure and splicing of lncRNAs encoded on Hsa21 was
also precisely recapitulated in the Tc1 mouse, despite the
absence of mouse orthologs. The majority (85%; Figure 4E) of
human noncoding splice sites were also detected in Tc1 and
noncoding exons were again near universally alternatively
spliced (98%; Figures 4A–4C). Furthermore, quantitative
splice-site usage and relative noncoding isoform abundance
was maintained as for human tissues (Figure 4D), indicating
that the local Hsa21 sequence is sufficient to establish splice-
site position and regulate the proportional inclusion of noncoding
exons by alternative splicing.
In contrast to splicing, we observed a global deregulation of
expression in the Tc1 mouse, as assessed by principal compo-
nent analysis or rank-correlation clustering (Figures S14A and
S14B). This effect is best illustrated at intergenic regions flanking
the NCAM2 locus, where numerous lncRNA genes that are
silenced in the human brain become deregulated, resulting in
aberrant expression in the Tc1 mouse brain (Figure S15A). In
fact, the expression of human protein-coding genes encoded
on Hsa21 was more similar to expression of their mouse ortho-
logs in corresponding mouse tissues than to the expression of
the same human genes encoded on Hsa21 in the Tc1 mouse
(Figures S14A and S14B). This deregulation was restricted to
the human chromosome, with tissue-specific expression profiles
still maintained across syntenic regions of the mouse genome in
Tc1 mouse (Figure S15B).
This analysis appears to highlight a distinction in the evolution
of expression and splicing regulation. The deregulation of human
gene expression in mouse cells is consistent with the reported
divergence of human and mouse regulatory elements, including
enhancers and transcription factor binding sites (Vierstra et al.,
2014; Villar et al., 2015). In contrast, splicing profiles were largely
recapitulated on Hsa21 in the Tc1 mouse, as has been observed
previously for protein-coding exons (Barbosa-Morais et al.,
2012). This implies that splicing is largely regulated by cis ele-
ments in the local chromosome sequence (Barash et al., 2010)Cell Systems 6, 245–255, February 28, 2018 251
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Figure 4. Splicing of Human Genes in the Tc1 Mouse
(A–C) Exon-intron structures assembled for the protein-coding gene DYRK1A and a novel lncRNA locus from human Hsa21 (A), mouse syntenic regions (B), and
on Hsa21 in the Tc1 mouse strain (C). Pie charts indicate the proportion of unique internal exons classified as constitutive (PSI > 95) or alternative, for protein-
coding exons (CDS) and untranslated exons at coding loci (UTR) and lncRNA exons.
(D) Plots show relative isoform abundance ofDYRK1A and novel lncRNA loci in human and Tc1 mouse, as indicated by PSI values for each internal exon (aligned
to exons in genemodels above). PSI values shown forDYRK1A aremeasured from human brain libraries (mean ± SD, n = 2) and lncRNA from testis libraries (n = 3).
(E) Density plots show global concordance of unique splice junction selection between humanHsa21 (mean ± SD, n = 2) and Tc1-Hsa21 libraries (n = 3) for human
exons. Density values are normalized relative to human Hsa21 libraries.and can be correctly interpreted by the mouse spliceosome. Our
findings imply that the splicing code is so highly conserved that
human-specific exons and noncoding RNAs without orthologs in
mouse are correctly spliced. This demonstrates deep conserva-
tion of the lexicon that governs splicing, even while the isoforms
produced undergo rapid diversification and turnover.
DISCUSSION
To overcome the expression-dependent bias in RNA-seq, which
impedes discovery and characterization of low-abundance tran-252 Cell Systems 6, 245–255, February 28, 2018scripts (Hardwick et al., 2016), we performed targeted RNA-seq
across human chromosome 21. The combination of single-mole-
cule and short-read RNA CaptureSeq enabled accurate resolu-
tion of isoform diversity and quantitative analysis of alternative
splicing at unprecedented depth.
Noncoding loci are, contrary to the impression from more
shallow surveys (Cabili et al., 2011; Derrien et al., 2012), en-
riched for alternative splicing, with noncoding exons being
near universally classified as alternative. This finding is consis-
tent with previous reports of lower splicing efficiency and
U2AF65 occupancy among lncRNAs than mRNAs, features
independently correlated with heightened alternative over
constitutive splicing (Mele´ et al., 2017; Mukherjee et al., 2017;
Tilgner et al., 2012).
Therefore, while protein-coding genes are constrained by the
requirement to maintain an ORF, it appears that no similar
constraint is imposed on noncoding RNA. This suggests that
noncoding exons are functionally modular, operating as
discrete cassettes that are recombined with maximum flexi-
bility. One can envision a scenario where individual noncoding
exons interact independently with other biomolecules (proteins,
RNAs, and/or DNA-motifs), organizing these around the scaf-
fold of a noncoding transcript. In this way, alternative isoforms
could assemble different collections of binding partners to
dynamically regulate cellular processes. The distinction be-
tween protein-coding and noncoding RNA was also evident
when comparing exons within ORFs with untranslated regions
of coding loci (located in 50 or 30 UTRs, or specific to noncoding
isoforms), implying similar modularity in the functional architec-
ture of untranslated regions.
Low expression is often cited as evidence against the func-
tional relevance of novel transcripts, such as the wide variety
of rare noncoding isoforms identified in our survey. However,
while weakly expressed genes/isoforms are unlikely to fulfill
structural or metabolic functions, there are precedents for these
fulfilling regulatory roles. For example, Marinov et al. (2014)
found the mRNAs of expressed transcription factors to be pre-
sent, on average, at just 3 copies per cell within a homoge-
neous cell line (GM12878). Single-cell studies routinely reveal
rare cell types within human tissues on the basis of their unique
gene expression profiles. These may be represented by just a
few cells within a community of hundreds or thousands of cells
(Grun et al., 2015; La Manno et al., 2016; Muraro et al., 2016).
Given that mRNAs encoding regulatory molecules such as tran-
scription factors are expressed at only a few copies per cell, the
regulatory factors that define the identity of rare cell types are
expected to be present at very low frequencies in whole-
tissue transcriptomes. It would be premature, therefore, to
discount the relevance of any transcript on the basis of low
abundance alone.
Moreover, while not every rare isoform is necessarily impor-
tant, and the promiscuous splicing we observed might simply
reflect a lack of selective pressure, noncoding RNAs collectively
form a large reservoir of transcriptional diversity from which mo-
lecular innovations might evolve and new genes may be born
(Kaessmann, 2010; Toll-Riera et al., 2009; Wu et al., 2011; Xie
et al., 2012). The use of alternative splicing to generate noncod-
ing transcriptional diversity and, thereby, drive gene evolution is
consistent with the divergence of noncoding exons reported
here. By contrast, the splicing code that governs such transcrip-
tional diversity remains closely conserved between human
and mouse.
Despite concerted efforts over the past decade, we are yet
to achieve a complete census of human gene expression.
Even our use of targeted single-molecule RNA-seq was insuf-
ficient to resolve the full complement of noncoding isoforms
encoded on Hsa21. Instead, we found a seemingly limitless
diversity of noncoding isoforms. Given the range of combi-
natorial possibilities, we suggest that the noncoding RNA
population may be inherently plastic, and that there does notexist a finite list of noncoding isoforms that can be feasibly
cataloged.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Samples
Total RNA samples from healthy adult tissues were acquired from a commercial vendor (Ambion Human RNA Survey Panel). Ambion
certifies that all of human-derived materials have been prepared from tissue obtained with consent from a fully informed donor or a
member of the donor’s family. Two replicate samples for human brain and kidney, and three replicates for testis were analyzed.
Mouse Samples
All animals were handled, housed, and used in the experiments in accordance with protocols approved by the Animal Ethics Com-
mittee of The University of Queensland, Brisbane, Australia. Three male mice (C57BL/6J x 129S8/SvEv) and 3 Tc1 female breeders
were imported from the Jackson Laboratory, Maine, USA. 10 x F1 pups produced from paired mating were toed for identification and
genotyping. Genotyping was performed on gDNA extracted from toe tissues using primers specific to human and mouse JAM2
genes. Three Tc1 F1 males and 3 WT littermates were sacrificed between 6 and 9 weeks of age, and testis, kidney and brain tissues
were immediately harvested in TRIzol reagent (Ambion), snap-frozen on dry ice and stored at -80C until processing.
K562 Cells
The human lymphoblast cell line, K562, was obtained from the American Type Culture Centre (ATCC). Cells were not independently
verified or tested for mycoplasma. Cells were cultured according to Coriell Institute’s growth protocols and standards. Briefly, K562
cells were cultured in RPMI 1640 medium (Gibco) supplemented with 10% FBS at 37C under 5%CO2. Cells (passage 9 or 10) were
grown to 80% confluence before RNA extraction.
METHOD DETAILS
Total RNA Extraction
Mouse Samples
Tissue samples (brain, kidney and testis), harvested in trizol and snap-frozen (see above), were defrosted on ice and 125 mg
MicroBeads (MoBio) were added to sample tubes. Tissues and cells were disrupted by 2 cycles of 45 sec at 6500 rpm on a tissue
homogenizer (Precellys) connected to a cooling system (Cryolis) keeping the samples temperature < 4C during the cell lysis proced-
ure. Bead-free cell lysates were transferred to a new 1.5 mL tube and RNA was immediately harvested, as above. Brain RNA was
extracted a second time in TRIzol due to high lipid contamination present after the first extraction.
K562 Cells
Total RNA was extracted in 3mL TRIzol reagent (Ambion). Extraction of the aqueous phase was performed using chlorophorm and
RNA precipitation was achieved with isopropanol. RNA pellets were washed in ice-cold 75% EtOH and allowed to dry before sus-
pension in DEPC-treated H2O.
Capture Enrichment
Oligonucleotide probes targeting the entire non-repetitive portion of Hsa21 (hg19) and its syntenic regions in the mouse (mm10)
genome, obtained using the UCSC Genome Browser liftOver tool, were designed and synthesized by Roche/NimbleGen. In total,
the array targeted 25.3 Mb encompassing 0.87% of the human genome and 20.3 Mb encompassing 0.77% of the mouse genome.
Total RNA samples were assessed for potential gDNA contamination by PCR and accordingly treated with Turbo DNAse (Ambion).
Samples were spiked with ERCC RNA spike-in controls (Jiang et al., 2011) to a final 1% concentration and rRNA-depleted using the
Ribo-Zero rRNA removal magnetic kit (Epicentre). cDNA libraries were prepared from rRNA-depleted samples using the Illumina
TruSeq stranded mRNA low-template kit. Pre-capture LMPCR amplified libraries were purified using AMPure XP beads (Beckman
Coulter Genomics), and successful library preparation was validated using a DNA 1000 kit (Agilent) on a Bioanalyser. Average library
sizes were 280-310 bp.
Capture hybridization was performed in 96-well plates, with hybridization probes incubated at 47C for 64-77 h. Post-capture
LMPCR amplification was performed for 17 cycles. Amplified post-capture libraries were purified using AMPure XP beads, and vali-
dated using a DNA 1000 kit on a Bioanalyzer. Samples that retained unincorporated primers were cleaned a second time using a
QIAquick PCR purification kit (Qiagen), and successful primer removal was validated on a Bioanalyzer. For a detailed protocol
see (Mercer et al., 2014).
PacBio SMRTbell Library Preparation and Single-Molecule Sequencing
A total of 4.5 mg of captured full-length cDNA was subjected to size fractionation using the Sage Science BluePippin system into four
size bins (0-2kb, 1-3kb, 3-6kb and 4-10kb). Eluted size fractions were subsequently re-amplified and purified with AMPure PB beads.
Size distributions of the fractions were checked for quality on a 2100 BioAnalyzer (Agilent).
Approximately 10 mg of purified amplicon was taken into Iso-Seq SMRTBell library preparation (https://pacbio.secure.force.com/
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(3-6kb and 4-10kb) were size-selected again using the Sage Science BluePippen system to remove trace amounts of small inserts.
A total of 24 SMRT Cells (6 cells for each of the size-selected SMRTBell library) were sequenced on the PacBio RS II platform using
P6-C4 chemistry with 3 to 4 hour acquisition time.
Short-Read (Illumina) Sequencing
Short-read sequencing libraries were prepared with the Illumina TruSeq stranded mRNA low-template kit. Libraries were sequenced
at the Garvan Institute (Sydney, NSW, Australia) on the Illumina HiSeq 2000 or Illumina HiSeq 2500 platforms, generating 2 x 101bp
and 2 x 125bp paired-end sequencing, respectively.
QUANTIFICATION AND STATISTICAL ANALYSIS
Validation of Hsa21 RNA CaptureSeq in K562 Cells
To establish the Hsa21 CaptureSeq approach we first carried out short-read sequencing (Illumina HiSeq 2000) on Hsa21-enriched
libraries from the human K562 cell-type (n = 3) and compared these to K562 samples analyzed in parallel by conventional RNA-Seq
(n = 3; Table S1).
Sequencing libraries were trimmed using TrimGalore (https://www.bioinformatics.babraham.ac.uk-/index.html; default
parameters), then aligned to a combined index of the hg19 reference genome and ERCC spike-in sequences. Alignment was
performed by STAR (Dobin et al., 2013) with the following custom parameters:
–twopassMode Basic –outFilterIntronMotifs RemoveNoncanonical –alignIntronMin 20 –alignIntronMax 500000y
On-target alignment rates were calculated by determining the number of uniquely mapped reads (MapQ=255) within Hsa21, as a
fraction of all uniquely mapped reads across hg19. The average fold-increase in on-target rate for CaptureSeq samples, relative to
non-captured samples, provides an estimate of the coverage enrichment achieved by capture (Table S1).
Relative abundances (in FPKM) of ERCCRNA spike-ins were determined using RSEM (Li and Dewey, 2011), allowing the accuracy
of transcript quantification to be assessed in captured/non-captured samples (Figures S2A and S2B). Progressively decreasing
enrichment at very high ERCC concentrations was observed due to saturation of CaptureSeq oligonucleotide baits, but is unlikely
to affect transcripts within the physiological range of gene expression (Clark et al., 2015; Mercer et al., 2014).
Single-Molecule Hsa21 Transcriptome Survey
To avoid potential artifacts associated with de novo transcript assembly, we analyzed Hsa21-enriched cDNA from human testis by
deep single-molecule PacBio sequencing. Testis was selected because it provides a broad survey of gene-content encoded on
Hsa21 (Soumillon et al., 2013).
The PacBio Iso-Seq ‘‘classify’’ protocol was used to generate full-length, non-chimeric (FLNC) reads (https://github.com/
PacificBiosciences/cDNA_primer). Briefly, for each sequencing ZMW, a circular consensus sequence (CCS) was generated. Each
CCS sequence was identified as full-length, non-chimeric if (1) both the 5’ and 3’ cDNA primer and the polyA tail preceding the
3’ primer was identified at the two ends; and (2) the sequence does not contain cDNA primers or polyA tails in the middle of the
sequence (indication of library artifacts). Because FLNC reads are supported by the presence of a polyA tail, they are considered
to represent mature transcript isoforms. Resolution of both sequencing primers ensures that FLNC reads have been sequenced
in completeness. However, the possibility of degradation due to the use of template switching without 5’ cap capture means that
some FLNC reads may not be biologically full-length.
FLNC reads were mapped to the human reference genome (hg19) using GMAP (Wu and Watanabe, 2005) and reads that mapped
to Hsa21 with maximum mapping confidence (MapQ=40) were retained. In total, 387,029 reads aligned to Hsa21, constituting 910
Mb of usable transcript sequence concentrated in 1.5% of the genome (Figures S3A and S3B; Tables S3 and 10).
To retain only high-qualitymulti-exonic single-molecule transcripts, we next discarded: (1) transcripts with < 3 exons; (2) transcripts
that contained one or more non-canonical introns (based on AG/GT splice sites); (3) any transcript that was entirely contained as a
partial fragment of a longer transcript or an annotated transcript (based on internal exon-intron-exon chain); (4) any transcript with the
following CuffCompare classifier: e, i, o, p, r, s (Trapnell et al., 2012). After filtering, we retrieved 101,478 full-length multi-exonic tran-
scripts (Figure S3B; Table S3). To our knowledge, this represents the deepest single-molecule transcriptome survey of a large
genome region ever performed.
Transcripts were next assessed for overlap with known protein-coding genes. Transcripts that shared exonic overlap (on the same
strand) with a known gene but not an identical internal exon-intron-exon chain were considered to represent novel isoforms of known
genes. Redundant transcripts (sharing identical internal exon-intron-exon chains) were collapsed.
These were classified as protein-coding or noncoding via the Coding Potential Assessment Tool (Wang et al., 2013; longest
ORF R 100 codons, coding potential score R 0.99). For coding transcripts we used TransDecoder to predict ORFs. Redundant
ORFs and fragments fully contained within longer ORFs were discarded. ORFs were overlapped with full-length transcripts to distin-
guish coding exons from noncoding exons belonging to coding loci, including spliced UTR exons and exons incorporated exclusively
into noncoding isoform variants at coding loci.
Transcripts that shared no exonic overlap with a known protein-coding gene (Gencode v19) and lacking a predicted ORF (CPAT;
longest ORF < 100 codons, coding potential score < 0.99) were classified as lncRNA transcripts. Redundant transcripts (sharing
identical internal exon-intron-exon chains) were collapsed.e3 Cell Systems 6, 245–255.e1–e5, February 28, 2018
Short-Read Hsa21 RNA CaptureSeq in Human Tissues
To obtain quantitative information about transcripts in our single-molecule Hsa21 profile, short-read sequencing (Illumina HiSeq
2500) was performed on duplicate Hsa21-enriched libraries from brain, kidney and testis. Sequencing libraries were trimmed and
aligned as described above (see above). On-target alignments rates were calculated as above (see 3.1) and reads that were uniquely
mapped (MapQ=255) within Hsa21were retained for further analysis. At least 100million alignments to Hsa21were obtained for each
tissue (Table S4).
Because de novo transcript assembly from short sequencing reads may generate incorrect transcript models, especially for low-
abundance isoforms (Hardwick et al., 2016), we did not perform transcript assembly. For all analyses of human tissues, the single-
molecule PacBio transcriptome described above (see above) was used as a reference, with spliced-short read alignments used to
quantitatively evaluate expression and splicing of PacBio transcripts.
The majority of spliced short-read alignment junctions were concordantly mapped to an intron in our single-molecule Hsa21 tran-
scriptome profile (Figure S3B). Likewise, the majority of unique internal exons in our single-molecule Hsa21 transcriptome were
correctly detected (both boundaries specified by R 3 spliced short-read alignment termini) in at least one tissue (Figure S3C).
This concordance with more accurate short-reads (Conesa et al., 2016) suggests that single-molecule isoforms were, in general,
correctly aligned to Hsa21, and their internal exon-intron-exon architecture was correctly resolved.
Discovery Saturation Curves
To generate discovery-saturation curves, short-read alignments from brain, kidney and testis were combined, then incrementally
subsampled from amaximumof450million alignments.We assessed the detection of introns and exons within our single-molecule
Hsa21 transcriptome by short-read alignments at each depth-increment. The analysis was limited to unique canonical introns and
unique internal exons (as opposed to terminal exons) since these should be precisely demarcated by short-read alignment junctions
at either end. An internal exon from our transcriptome was considered to be detected within a given library if both boundaries were
specified byR 3 spliced short-reads. An intron from our transcriptome was considered to be detected within a given library if it was
spanned byR 3 spliced short-read alignment junctions, mapping exactly to its 5’ and 3’ ends.
Percent Splice Inclusion (PSI) Values
To further assess alternative splicing, we calculated a Percent Splice Inclusion (PSI) score for each internal exon in our Hsa21
transcriptome, as has been done previously (Barbosa-Morais et al., 2012; Tilgner et al., 2015). For each exon, we counted spliced
reads that used its 5’ splice site (In1) and 3’ splice site (In2) and spliced reads that spanned/skipped the exon (Out). The PSI value
for that exon was then calculated as:
PSI=
ðIn1+ In2Þ=2
Out+ ðIn1+ In2Þ=2 3 100
We confirmed that the occurrence of lower inclusion frequencies among noncoding exons (median PSI = 55.5%) than protein-cod-
ing exons (median PSI = 90.5%; Figure 2B) was not simply caused their lower gene expression, since exon-PSI and overall gene
expression metrics were independent from one and other (Figure S7). Applying a threshold of PSI > 95% to distinguish constitutive
from alternatively spliced exons, as has been done previously (Barbosa-Morais et al., 2012; Tilgner et al., 2015), almost all noncoding
exons (97%) would be classified as alternative. We note that the use of a single, essentially arbitrary, PSI threshold is simplistic. How-
ever, this difference was indicative of a clear, population-wide depletion of PSI scores among noncoding exons, relative to their
protein-coding counterparts, with a clear difference observable at any chosen threshold (Figure 2B). The use of PacBio reads as
a scaffold for calculating PSI scores ensures we are working with accurate transcripts (free of potential artifacts from transcript
assembly). However, PacBio reads are less suitable for quantitative analyses because (i) size fractionation and heavy PCR amplifi-
cation during the PacBio library preparation may distort transcript abundances within the population and (ii) saturating read-depth is
required for accurate analyses of splicing. Therefore we consider our combined approach to be themost reliable way to assess alter-
native splicing. PSI scores were also calculated independently using only spliced PacBio long-read alignments, rather than spliced
short-reads. This analysis produced similar results (Figure S9).
Comparison of Human and Mouse Transcriptomes
To perform a fair comparison of transcriptome dimensions between human andmouse profiles, we generated de novo transcriptome
assemblies for each, at matched depth, rather than using the single-molecule human transcriptome (which would skew the compar-
ison, since long-read sequencing was not performed on mouse tissues). While we note that de novo assembly may produce some
spurious transcript models, the comparison of transcriptome dimensions between human and mouse is fair, since biases should
affect both assemblies equally. Additionally, because assemblies were generated without the support of reference gene catalogs,
they are not affected by discrepancies in the quality/completeness of human/mouse genome annotation.
After aligning reads to hg19 or mm10 with STAR and retaining only on-target, uniquely mapped reads (see above), libraries were
subsampled to achieve a maximum matched depth of 100 million alignments per tissue (Tables S4 and S7). Assemblies were
generated from these matched libraries using StringTie (Pertea et al., 2015). Assemblies from replicates for each tissue were merged
using Cuffmerge (Trapnell et al., 2012). Full-length assembled transcript sequences were filtered and classified as above (see above).Cell Systems 6, 245–255.e1–e5, February 28, 2018 e4
Conservation Analyses
To assess genomic-level sequence constraint we calculated average per-base PhyloP scores from 100 Vertebrate MultiZ align-
ments, obtained via the UCSC Genome Browser, within noncoding exons. Intergenic and intronic sequences of equivalent size
were selected at random and used to provide a measure of neutral/background conservation. In addition to noncoding exons, we
examined noncoding splice site dinucleotides (AG/GT), which were more strongly conserved than internal exon sequences, as
well as annotated transcription factor binding sites and DHS sites on Hsa21 (Figure S12).
While PhyloP scores provide a useful measure of constraint on genomic sequence (inferred by comparison to other vertebrate ge-
nomes), our targeted transcriptome survey of syntenic human-mouse genome regions, allowed us to evaluate whether conserved
exonic splice site nucleotides are actually transcribed and/or used as splice sites in both lineages. To do so, we lifted splice-site di-
nucleotides (AG/GT) demarcating human noncoding exons to themouse genome using the UCSC liftOver tool. If a human splice-site
dinucleotide was found to be conserved in the mouse genome, we tested to see if an equivalent junction could be found among
mouse CaptureSeq alignments. While 15% of human noncoding splice site nucleotides are conserved in mouse at the genomic
level, a corresponding splice site was found in mouse for fewer than 2% of human sites.
Analysis of Hsa21 Splicing and Expression in the Tc1 Mouse
The Tc1 mouse strain is a model for trisomy-21 that carries a stable copy of Hsa21 (Yu et al., 2010). We applied short-read RNA
CaptureSeq (Illumina HiSeq 2500) to provide saturating coverage of both the Hsa21 transcriptome and syntenicmouse chromosome
regions in Tc1 mouse tissues (brain, kidney and testis; Table S9). To assess alternative splicing we calculated PSI scores (see above)
for protein-coding and noncoding exons expressed on Hsa21 or themouse syntenic regions in Tc1 tissues.We compared PSI values
at Tc1 exons to their equivalent exons detected in human or mouse, and between orthologous exons from the two species (Fig-
ure S13). To perform global comparisons of alternative splicing profiles among orthologous human/mouse exons, we clustered
human/mouse/Tc1 mouse tissues according to their PSI scores using either principle component analysis or rank-correlation clus-
tering (Figure S14). We did the same for gene expression, using FPKM values for orthologous genes rather than PSI scores.
DATA AND SOFTWARE AVAILABILITY
Raw sequencing data and a combined transcriptome annotation are available via the NCBI Gene Expression Omnibus (GEO) under
the following accession: GSE99637.e5 Cell Systems 6, 245–255.e1–e5, February 28, 2018
